BL22 in HCL after Immunotoxin
Showing 1 - 25 of >10,000
Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)
Active, not recruiting
- Hairy Cell Leukemia
- Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022
Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)
Active, not recruiting
- Hairy Cell Leukemia
- Moxetumomab Pasudotox-tdfk
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)
Recruiting
- Hairy Cell Leukemia
- Hairy Cell Leukemia Variant
- CD22CART cell infusion
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))
Completed
- Healthy
- Gleptomet 50/1000(Metformin HCl & Sitagliptin)
- Janumet 50/1000(Metformin HCl & Sitagliptin)
-
Cairo, EgyptGenuine Research Center GRC
Mar 22, 2023
Post Operative Pain Trial in United States (SABER-Bupivacaine (Part 1), SABER-Bupivacaine (Part 2), Saline Placebo)
Completed
- Post Operative Pain
- SABER-Bupivacaine (Part 1)
- +3 more
-
Florence, Alabama
- +20 more
Jun 21, 2021
Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)
Completed
- Mesothelioma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 28, 2022
Allergy Trial (cetirizine HCl Gummy, Zyrtec tablet 10mg)
Not yet recruiting
- Allergy
- cetirizine HCl Gummy
- Zyrtec tablet 10mg
- (no location specified)
May 18, 2022
Hairy Cell and Other Leukemias, and to Develop Recombinant
Recruiting
- Hairy Cell Leukemia (HCL)
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Shoulder Pain Trial in New York (Liposomal Bupivacaine, 0.5% Bupivacaine HCL)
Completed
- Shoulder Pain
- Liposomal Bupivacaine
- 0.5% Bupivacaine HCL
-
New York, New YorkNYU Langone Health
Jan 3, 2022
Type 1 Diabetes, Exercise Trial in Roma (Moderate intensity exercise, High intensity interval exercise, Combined exercise)
Recruiting
- Type 1 Diabetes
- Exercise
- Moderate intensity exercise
- +3 more
-
Roma, RM, ItalyAzienda Ospedaliera Sant'Andrea
Feb 16, 2023
Diabetes, Type 2 Trial in Firenze (Acupuncture)
Recruiting
- Diabetes Mellitus, Type 2
- Acupuncture
-
Firenze, ItalyDiabetologia AOU Careggi
Jul 19, 2022
Local Anesthetic Complication Trial in Ankara (Articaine Hydrochloride + Epinephrine, Lidocaine Hydrochloride + Epinephrine)
Recruiting
- Local Anesthetic Complication
- Articaine Hydrochloride + Epinephrine
- Lidocaine Hydrochloride + Epinephrine
-
Ankara, TurkeyAnkara Yıldırım beyazıt University, Faculty of Dentistry
Aug 30, 2023
Mesothelioma Trial run by the NCI (LMB-100, Pembrolizumab)
Terminated
- Mesothelioma
- LMB-100
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 3, 2021
Hypotension, Anesthesia Trial in Peshawar (Phenylephrine Hydrochloride 4 mg, Phenylephrine Hydrochloride 8 mg)
Completed
- Hypotension
- Anesthesia
- Phenylephrine Hydrochloride 4 mg
- Phenylephrine Hydrochloride 8 mg
-
Peshawar, Khyber Pakhtunkhwa, PakistanRehman Medical Institute
Apr 21, 2022
Oncology Patients Receiving Chemo Trial in United States (Cetirizine HCl 10 mg/mL, Diphenhydramine 50 mg/mL, anti-CD20 such as
Completed
- Oncology Patients Receiving Chemotherapy
- Cetirizine HCl 10 mg/mL
- +2 more
-
Napa, California
- +6 more
Apr 25, 2022
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Postoperative Pain, Cesarean Section Trial in Charlotte (Liposomal bupivacaine, Bupivacaine HCl)
Suspended
- Postoperative Pain
- Cesarean Section
- Liposomal bupivacaine
- Bupivacaine HCl
-
Charlotte, North CarolinaAtrium Health
Jan 27, 2023
Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)
Completed
- Type1 Diabetes
- HCL
- +3 more
-
Palo Alto, California
- +5 more
Oct 31, 2022
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Postoperative Pain Management Trial in United States (EXPAREL and bupivacaine HCl, Bupivacaine HCl)
Terminated
- Postoperative Pain Management
- EXPAREL and bupivacaine HCl
- Bupivacaine HCl
-
Gilbert, Arizona
- +14 more
Oct 12, 2021
CLL, SLL, HCL Trial in Dresden
Recruiting
- CLL
- +7 more
-
Dresden, Sachsen, GermanyBAG Freiberg-Richter, Jacobasch, Wolf, Illmer
Apr 29, 2022
Advanced Solid Tumor Trial (ZG0895 Hydrochloride for Injection)
Not yet recruiting
- Advanced Solid Tumor
- ZG0895 Hydrochloride for Injection
- (no location specified)
May 25, 2023
Video Assisted Thoracic Surgery Trial in Cleveland (Bupi HCI and lipo bupi, Bupi HCI)
Recruiting
- Video Assisted Thoracic Surgery
- Bupi HCI and lipo bupi
- Bupi HCI
-
Cleveland, OhioCleveland Clinic
Jan 10, 2022
Migraine Without Aura Trial in Ankara (Ibuprofen 400 mg, Dexketoprofen)
Completed
- Migraine Without Aura
- Ibuprofen 400 mg
- Dexketoprofen
-
Ankara, TurkeyKecioren Training and Research Hospital
Dec 12, 2021
Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,
Active, not recruiting
- Neoplasms With Mesothelin Expression
- +3 more
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2022